Ecolab offers Asepti-Wipe II which is registered with EPA with an Influenza A claim. Contact: RHONDA SCHULZ Associate Director, Product Registration & Compliance Law & Regulatory Affairs ECOLAB 370 Wabasha Street North - EUC 9 St. Paul, MN 55102-1390 T 651-293-4026 F 651-225-3122 rhonda.schulz at ecolab.com Georjean Adams At 7:59 AM -0700 9/9/09, Gangmark.Carolyn at epamail.epa.gov wrote: >Hello P2 Tech Community. My colleague Cathe Bell (message below) is >seeking feedback re disinfectant wipes to be used this fall to help >prevent cases of H1N1 in our EPA R10 office. Since many of you have >expertise in this area and work in offices where similar decision making >is underway... thought that we might all benefit from the collective >wisdom. Thoughts??? Thanks so much. > >Carolyn Gangmark >U.S. EPA Region 10 >1200 6th Ave. Suite 900 AWT-128 >Seattle, WA 98101 >Phone (206) 553-4072 >FAX (206) 553-8509 > >If we don't get climate right - nothing else matters. >----- Forwarded by Carolyn Gangmark/R10/USEPA/US on 09/09/2009 07:51 AM >----- > > Cathe > Bell/R10/USEPA/U > S To > > 09/08/2009 05:36 cc > PM OARM-OA-SHEMD-SHEMPMGRS > Subject > Products for H1N1 mitigation: > Could you give me your thoughts > > > > > > > > > >Colleagues: > > I'd like both your personal and professional opinion about some >products that I am considering purchasing to help reduce the impact of >H1N1 in our workplace this winter. I've contacted you because I value >your thinking on the subject. I trust that your combined experience >will help me select products that are as powerful as we might need, but >as benign as possible. > >Here is the situation: to equip staff to reduce flu transmission in the >workplace, I'm going to follow a strategy which includes > 1. flu shots: both seasonal and H1N1 > 2. messages on ways to reduce disease transmission by personal >hygiene and practices, and > 3. provision of sanitizers to be used in places where disease >transmission is more likely. > >I hesitate, for a number of reasons to bring additional chemicals into >our workplace. However, the guidance I'm receiving, both internal to >R10 and from CDC, encourages me to consider these as components of an >public health approach which will be more effective than "business as >usual." > >The elements are simple: a limited amount of sanitizing wipes and hand >sanitizers will be stationed around the floors to be used in areas the >public frequents or staff congregates. The wipes will also be made >available to IT staff to destroy microbes before they handle what is >likely to be contaminated equipment. > >I'd like your opinions on the wipe sanitizers, specifically. I've >attached a sheet with the names and characteristics of some products >I've investigated. I'd like to hear your opinions on whether and how to >station these, and, more importantly, arguments for selecting specific >products. > >Now, I'm going to bias you (stop reading, review the information and >respond, if you'd like). I'm inclined to opt for simple chemicals >rather that the various takes on benzalkonium chloride and complex >antimicrobials. From what I've read, all of these products are almost >equally effective. The difference between the alcohol, chlorine, and >hydrogen peroxide based sanitizers and some of the more complex >materials is that the latter's antimicrobial action may last a bit >longer, longer on the order of hours. For our uses, I'm not sure that >is critical. There are three issues I'd like to weight toward: a) that >the wipes are not irritating, particularly to more sensitive members of >our community, b) manufacturing of the product is relatively simple and >sustainable, and c) the product does not contribute to antimicrobial >resistance. Look at my list and know I'm open to your thoughts. > >Again, these wipes will be used to clean up after sneezing/coughing, if >someone sick has been in an area, in offices where a sick person has >left within 48 hours and office materials must be accessed, in public >greeting areas, and to the PC Hotline and administrative support staff >to use when they handle staff equipment. > > >Note: manufacturing bleach may involve mercury cells (to be phased out >by 2020), a drawback. Or they may depend on membranes. > >(See attached file: wipes_product comparisons for comment.doc) > > >SHEMPMGRS: this is for your information only, so that you do not need >to duplicate this work. No comments are expected, although you know I'd >welcome your educated opinions! > >>From the Desk of >Cathe Bell >Safety, Health and Environmental Management >US EPA Region 10, M/S OMP-077 >Seattle, WA 98101 >Tel: 206-553-0308 >BlackBerry: 206-399-9394 Fax: 206-553-0714 > > >OMP wants to hear from you, click here to provide feedback. > > >Safety, Health and Environmental Management, R10 Intranet > >* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * > >p2tech is hosted by the Great Lakes Information Network (GLIN): > >http://www.great-lakes.net > >To search the archive: http://www.great-lakes.net/lists/p2tech/ > >All views and opinions presented above are solely those of the author >or attributed source and do not necessarily reflect those of GLIN or >the Great Lakes Commission. > >* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * > >Attachment converted: Macintosh HD:wipes_product >compa#1901923.doc (WDBN/«IC») (01901923) -- EHS Strategies, Inc. - enabling organizations to meet their EHS vision http://ehsstrategies.com 651-204-3371 -------------- next part -------------- A non-text attachment was scrubbed... Name: wipes_product comparisons for comment.doc Type: application/msword Size: 31232 bytes Desc: not available Url : http://www.great-lakes.net/lists/p2tech/attachments/20090909/73141d8d/attachment.doc